VAERS Explorer
Back to explore

Report #2850393

Received Jul 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
Mar 1, 2023
Onset
Mar 1, 2023
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC20PNEUMO (PREVNAR20)PFIZER\WYETHUNK——

Symptoms (1)

Rash

Symptom narrative

She had a large rash on her back that persisted for approximately one week; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. An adult female patient (unknown if pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), in Mar2023 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "drug allergy" (unspecified if ongoing). Concomitant medication(s) included: SINGULAIR, start date: Mar2023. The following information was reported: RASH (non-serious) with onset Mar2023, outcome "recovered" (Mar2023), described as "She had a large rash on her back that persisted for approximately one week". Therapeutic measures were not taken as a result of rash. Additional information: Patient received Prevnar 20 from doctor's office on same day as starting Singulair. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.

Medical history

Medical History/Concurrent Conditions: Drug allergy

Other medications

SINGULAIR